Piedmont Cancer Institute

Institution (Healthcare)

Homepage ROR

Also Known As

Peachtree Hematology Oncology Consultants, Piedmont Cancer Institute · Acronym: PCI

1.7K

Publications

125.4K

Citations

Authors

386

Concepts

About

Piedmont Cancer Institute is a healthcare institution in Atlanta, United States known for medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	427	31.7K
2	Health Sciences	25	115	6.2K
3	Engineering	13	28	2K
4	Natural Sciences	9	27	2.9K
5	Nursing	2	6	80

Piedmont Cancer Institute

1.7K

Publications

125.4K

Citations

Page 1

	Year	Citations
Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society Andrew M. D. Wolf, Elizabeth T. H. Fontham, Timothy R. Church, CA A Cancer Journal for Clinicians Epidemiology Of CancerPopulation Health SciencesOncologyCancer DetectionClinical Epidemiology	2018	2K
Initial genome sequencing and analysis of multiple myeloma Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats, Nature	2011	1.4K
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Rashmi K. Murthy, Sherene Loi, Alicia Okines, New England Journal of Medicine	2019	1.3K
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients Alice O. Kamphorst, Rathi N. Pillai, Shu Yang, Proceedings of the National Academy of Sciences	2017	847
mtDNA mutations increase tumorigenicity in prostate cancer John A. Petros, Amanda K. Baumann, Eduardo Ruiz‐Pesini, Proceedings of the National Academy of Sciences	2005	831
Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition Shi-Yong Sun, Laura M. Rosenberg, Xuerong Wang, Cancer Research	2005	806
Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells Robert S. Ohgami, Dean R. Campagna, Eric Lieberman Greer, Nature Genetics Iron DeficiencyErythroid CellsBiochemistryHeme HomeostasisIron Metabolism	2005	769
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nature Medicine Hematological MalignancyMagnetismm-3 Trial ResultsMedicineBispecific AntibodySubcutaneous Elranatamab	2023	483
Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding Xiaohu Gao, Warren C. W. Chan, Shuming Nie Journal of Biomedical Optics	2002	420
T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project Sohil H. Patel, Laila Poisson, Daniel J. Brat, Clinical Cancer Research	2017	411

Page 1